Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have been given an average rating of “Strong Buy” by the five ratings firms that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a strong buy recommendation.
A number of equities analysts have recently commented on the stock. Rosenblatt Securities raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, March 7th. Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Roth Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th.
Check Out Our Latest Stock Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- What does consumer price index measure?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- Pros And Cons Of Monthly Dividend Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Profit From Growth Investing
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
